Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Intake | 14 | 2021 | 77 | 2.810 |
Why?
|
| Sarcopenia | 8 | 2021 | 26 | 2.490 |
Why?
|
| Intensive Care Units | 16 | 2021 | 247 | 2.370 |
Why?
|
| Enteral Nutrition | 13 | 2021 | 61 | 2.300 |
Why?
|
| Parenteral Nutrition | 10 | 2021 | 20 | 2.290 |
Why?
|
| Nutritional Status | 14 | 2021 | 53 | 2.290 |
Why?
|
| Critical Care | 8 | 2021 | 113 | 2.210 |
Why?
|
| Critical Illness | 17 | 2021 | 109 | 2.160 |
Why?
|
| Malnutrition | 9 | 2019 | 22 | 2.130 |
Why?
|
| Nutritional Support | 8 | 2021 | 23 | 1.960 |
Why?
|
| Acute Lung Injury | 6 | 2018 | 18 | 1.620 |
Why?
|
| Body Composition | 6 | 2022 | 66 | 1.520 |
Why?
|
| Dietetics | 5 | 2020 | 9 | 1.510 |
Why?
|
| Hypothyroidism | 3 | 2023 | 69 | 1.200 |
Why?
|
| Humans | 58 | 2023 | 23541 | 1.100 |
Why?
|
| Respiratory Insufficiency | 6 | 2023 | 48 | 1.080 |
Why?
|
| Nutritional Requirements | 7 | 2021 | 16 | 1.050 |
Why?
|
| Neoplasms | 3 | 2017 | 223 | 0.980 |
Why?
|
| Respiratory Muscles | 3 | 2021 | 15 | 0.960 |
Why?
|
| Muscle, Skeletal | 7 | 2021 | 333 | 0.960 |
Why?
|
| Blood Glucose | 6 | 2021 | 99 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2022 | 605 | 0.920 |
Why?
|
| Hand Strength | 2 | 2021 | 49 | 0.850 |
Why?
|
| Male | 37 | 2022 | 12743 | 0.830 |
Why?
|
| Female | 37 | 2022 | 13239 | 0.820 |
Why?
|
| Research Design | 2 | 2021 | 163 | 0.750 |
Why?
|
| Nutrition Assessment | 8 | 2019 | 40 | 0.720 |
Why?
|
| Thyroxine | 4 | 2023 | 80 | 0.700 |
Why?
|
| Nutritionists | 2 | 2020 | 2 | 0.700 |
Why?
|
| C-Reactive Protein | 4 | 2016 | 92 | 0.690 |
Why?
|
| Adult | 22 | 2023 | 7168 | 0.680 |
Why?
|
| Hospitalization | 7 | 2018 | 292 | 0.670 |
Why?
|
| Medical Staff Privileges | 1 | 2020 | 2 | 0.660 |
Why?
|
| Cachexia | 2 | 2017 | 10 | 0.660 |
Why?
|
| Prescriptions | 1 | 2020 | 16 | 0.650 |
Why?
|
| Middle Aged | 26 | 2021 | 8134 | 0.640 |
Why?
|
| Muscle Strength | 2 | 2019 | 102 | 0.640 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 778 | 0.620 |
Why?
|
| Insulin | 4 | 2013 | 79 | 0.610 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 5 | 0.600 |
Why?
|
| Triiodothyronine | 3 | 2023 | 91 | 0.570 |
Why?
|
| Underage Drinking | 1 | 2017 | 1 | 0.550 |
Why?
|
| Thyrotropin | 2 | 2020 | 49 | 0.540 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 14 | 0.540 |
Why?
|
| Dietary Proteins | 5 | 2016 | 26 | 0.530 |
Why?
|
| Prevalence | 8 | 2021 | 395 | 0.530 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 24 | 0.530 |
Why?
|
| Personality | 1 | 2017 | 43 | 0.530 |
Why?
|
| Self Report | 1 | 2018 | 195 | 0.530 |
Why?
|
| Retrospective Studies | 10 | 2021 | 3122 | 0.510 |
Why?
|
| Smoking | 1 | 2017 | 168 | 0.500 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 271 | 0.470 |
Why?
|
| Aged | 20 | 2021 | 7572 | 0.460 |
Why?
|
| Respiration, Artificial | 8 | 2021 | 102 | 0.450 |
Why?
|
| Hypoglycemia | 1 | 2013 | 12 | 0.400 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2011 | 3 | 0.360 |
Why?
|
| Prealbumin | 1 | 2011 | 4 | 0.360 |
Why?
|
| APACHE | 6 | 2021 | 27 | 0.350 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 68 | 0.350 |
Why?
|
| Eating | 1 | 2010 | 46 | 0.320 |
Why?
|
| Inflammation | 1 | 2011 | 237 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2010 | 96 | 0.320 |
Why?
|
| Patient Care Team | 1 | 2010 | 110 | 0.310 |
Why?
|
| Body Mass Index | 7 | 2022 | 403 | 0.310 |
Why?
|
| Diet | 1 | 2010 | 182 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 244 | 0.280 |
Why?
|
| Adipose Tissue | 2 | 2022 | 73 | 0.280 |
Why?
|
| Affect | 2 | 2018 | 58 | 0.270 |
Why?
|
| Hospital Mortality | 3 | 2017 | 133 | 0.270 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 1045 | 0.270 |
Why?
|
| Hyperglycemia | 4 | 2013 | 28 | 0.250 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 294 | 0.250 |
Why?
|
| Growth | 1 | 2005 | 6 | 0.240 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2005 | 5 | 0.240 |
Why?
|
| Ketone Bodies | 1 | 2005 | 4 | 0.240 |
Why?
|
| Ketosis | 1 | 2005 | 7 | 0.230 |
Why?
|
| Obesity | 4 | 2016 | 294 | 0.230 |
Why?
|
| Depression | 2 | 2018 | 368 | 0.220 |
Why?
|
| Child Development | 1 | 2005 | 68 | 0.220 |
Why?
|
| Epilepsy | 1 | 2005 | 68 | 0.220 |
Why?
|
| Pilot Projects | 3 | 2021 | 379 | 0.220 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 276 | 0.210 |
Why?
|
| Length of Stay | 5 | 2014 | 305 | 0.210 |
Why?
|
| Risk Factors | 4 | 2021 | 1997 | 0.210 |
Why?
|
| Postoperative Complications | 2 | 2021 | 837 | 0.200 |
Why?
|
| Noninvasive Ventilation | 1 | 2023 | 11 | 0.200 |
Why?
|
| Maximal Respiratory Pressures | 2 | 2019 | 3 | 0.200 |
Why?
|
| Inpatients | 2 | 2019 | 116 | 0.200 |
Why?
|
| Academies and Institutes | 2 | 2020 | 11 | 0.200 |
Why?
|
| Physicians | 2 | 2018 | 108 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2020 | 119 | 0.190 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 3767 | 0.190 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 28 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2020 | 1532 | 0.180 |
Why?
|
| Muscles | 1 | 2021 | 56 | 0.180 |
Why?
|
| Sample Size | 1 | 2021 | 17 | 0.180 |
Why?
|
| Child | 3 | 2018 | 1178 | 0.180 |
Why?
|
| Coma | 1 | 2021 | 5 | 0.170 |
Why?
|
| Delirium | 1 | 2021 | 12 | 0.170 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 12 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2013 | 1465 | 0.170 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 19 | 0.170 |
Why?
|
| Documentation | 2 | 2018 | 21 | 0.170 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 6 | 0.170 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2020 | 7 | 0.160 |
Why?
|
| Long-Term Care | 1 | 2020 | 56 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 36 | 0.160 |
Why?
|
| Muscular Atrophy | 2 | 2016 | 11 | 0.160 |
Why?
|
| Medicare | 1 | 2020 | 107 | 0.150 |
Why?
|
| Hospitals | 1 | 2020 | 157 | 0.150 |
Why?
|
| Adolescent | 3 | 2017 | 1952 | 0.150 |
Why?
|
| Patients | 1 | 2019 | 31 | 0.150 |
Why?
|
| Overweight | 2 | 2016 | 68 | 0.150 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 1 | 0.140 |
Why?
|
| Clinical Coding | 1 | 2018 | 5 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2018 | 6 | 0.140 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 14 | 0.140 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 32 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 43 | 0.140 |
Why?
|
| Fatigue | 1 | 2018 | 46 | 0.140 |
Why?
|
| Professional Competence | 1 | 2018 | 38 | 0.140 |
Why?
|
| Emotions | 1 | 2018 | 70 | 0.140 |
Why?
|
| Puberty | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2018 | 58 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2017 | 6 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2016 | 145 | 0.130 |
Why?
|
| Internet | 1 | 2018 | 82 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 21 | 0.130 |
Why?
|
| Child Behavior | 1 | 2017 | 28 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2020 | 3093 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 443 | 0.130 |
Why?
|
| Tomography | 2 | 2013 | 13 | 0.130 |
Why?
|
| Thyroid Function Tests | 1 | 2016 | 12 | 0.130 |
Why?
|
| United States | 2 | 2020 | 1837 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 53 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 154 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 36 | 0.130 |
Why?
|
| Quality of Life | 2 | 2018 | 565 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2016 | 24 | 0.130 |
Why?
|
| Health Surveys | 1 | 2016 | 80 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 27 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 505 | 0.130 |
Why?
|
| Point-of-Care Testing | 1 | 2016 | 27 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 10 | 0.120 |
Why?
|
| Liver Failure | 1 | 2015 | 10 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2016 | 11 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 324 | 0.120 |
Why?
|
| Dyspnea | 1 | 2016 | 36 | 0.120 |
Why?
|
| MEDLINE | 1 | 2015 | 5 | 0.120 |
Why?
|
| Palliative Care | 1 | 2016 | 107 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2016 | 203 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 431 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 110 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 40 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2015 | 391 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1050 | 0.110 |
Why?
|
| Logistic Models | 3 | 2016 | 357 | 0.110 |
Why?
|
| Exercise | 1 | 2016 | 400 | 0.100 |
Why?
|
| Pain | 1 | 2016 | 348 | 0.100 |
Why?
|
| Nutrition Therapy | 1 | 2012 | 6 | 0.100 |
Why?
|
| Nausea | 2 | 2010 | 24 | 0.100 |
Why?
|
| Vomiting | 2 | 2010 | 18 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 159 | 0.090 |
Why?
|
| Cognition | 1 | 2018 | 948 | 0.090 |
Why?
|
| Health Facilities | 1 | 2011 | 26 | 0.090 |
Why?
|
| Cost Savings | 1 | 2010 | 29 | 0.090 |
Why?
|
| Urban Population | 1 | 2011 | 134 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 112 | 0.080 |
Why?
|
| Liver | 1 | 2011 | 141 | 0.080 |
Why?
|
| Body Weight | 2 | 2014 | 129 | 0.080 |
Why?
|
| Anorexia | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Stability | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Compounding | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2010 | 10 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 31 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 11 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2020 | 83 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 146 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2010 | 99 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2010 | 24 | 0.080 |
Why?
|
| Ventilator Weaning | 1 | 2010 | 30 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 56 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 254 | 0.080 |
Why?
|
| Chicago | 4 | 2019 | 818 | 0.080 |
Why?
|
| Biomarkers | 1 | 2011 | 482 | 0.070 |
Why?
|
| Patient Selection | 1 | 2010 | 170 | 0.070 |
Why?
|
| Nutritional Sciences | 1 | 2008 | 7 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 98 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 1101 | 0.060 |
Why?
|
| Body Height | 1 | 2005 | 31 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 23 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 58 | 0.050 |
Why?
|
| Infant | 1 | 2005 | 488 | 0.050 |
Why?
|
| Cannula | 1 | 2023 | 8 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2005 | 583 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2023 | 16 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2023 | 58 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 58 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 27 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 27 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1492 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 20 | 0.040 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2020 | 9 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 1745 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 248 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 220 | 0.040 |
Why?
|
| Societies | 1 | 2018 | 6 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 85 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2018 | 67 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 123 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 21 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 64 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 52 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 59 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 127 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 81 | 0.030 |
Why?
|
| Terminal Care | 1 | 2016 | 23 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 35 | 0.030 |
Why?
|
| Medical Subject Headings | 1 | 2015 | 1 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 146 | 0.030 |
Why?
|
| Search Engine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 72 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 73 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 12 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 603 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2016 | 129 | 0.030 |
Why?
|
| Body Fluid Compartments | 1 | 2013 | 4 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 40 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 168 | 0.030 |
Why?
|
| Minority Groups | 1 | 2013 | 66 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 51 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 34 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2013 | 31 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 819 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 229 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 163 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 393 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 112 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 52 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 128 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 453 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 16 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 126 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 234 | 0.020 |
Why?
|
| Insulin Glargine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 2006 | 2 | 0.020 |
Why?
|
| Management Service Organizations | 1 | 2006 | 1 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 140 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 35 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2006 | 44 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 322 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2008 | 202 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2008 | 204 | 0.010 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 2 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 317 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2004 | 12 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 25 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 33 | 0.010 |
Why?
|